Form IRANNOTICE DANAHER CORP /DE/
DANAHER CORPORATION
2200 Pennsylvania Avenue, N.W., Suite 800W
Washington, DC 20037
April 22, 2024
VIA EDGAR
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
| Re: | Notice of Disclosure Filed in Exchange Act Quarterly Report Under Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Exchange Act | |||||||
Ladies and Gentlemen:
This filing is to provide notice to the U.S. Securities and Exchange Commission (the “SEC”) that Danaher Corporation’s Quarterly Report on Form 10-Q for the period ended March 29, 2024, which was filed with the SEC on April 22, 2024, contains information required to be disclosed by Section 219 of the Iran Threat Reduction and Syria Human Rights Act of 2012 and Section 13(r) of the Securities Exchange Act of 1934, as amended. Such disclosure can be found under the heading “Item 5. Other Information—Disclosure Pursuant to Section 13(r) of the Exchange Act” in such Quarterly Report on Form 10-Q.
Respectfully submitted,
| DANAHER CORPORATION | ||||||||
| By: | /s/ James O’Reilly | |||||||
| Name: | James O’Reilly | |||||||
| Title: | Senior Vice President, Deputy General Counsel and Secretary | |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Danaher Schedules Second Quarter 2026 Earnings Conference Call
- Visionary Announces Effective Date of Share Consolidation
- Masimo Receives FDA 510(k) Clearance for AI-Enabled Opioid-Induced Respiratory Depression (OIRD) Detection on Radius VSMĀ® to Help Identify Respiratory Risk Sooner
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share